Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Emery

Showing results (541-550 of 586) with videos related to

Pageof 59
Sort By:
Annals of the Rheumatic Diseases|December 7, 2010
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesS van Assen, N Agmon-Levin, O Elkayam, et al.
Arthritis and Rheumatism|August 16, 2000
Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine aloneS M Proudman, P G Conaghan, C Richardson, et al.
Annals of the Rheumatic Diseases|August 6, 2013
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)J L Nam, E Villeneuve, E M A Hensor, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapseC H Burgoyne, S L Field, A K Brown, et al.
Arthritis and Rheumatism|October 31, 2007
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinaprilA E Gliddon, C J Doré, C M Black, et al.
Nature|October 7, 2021
Fine-regolith production on asteroids controlled by rock porosityS Cambioni, M Delbo, G Poggiali, et al.
Annals of the Rheumatic Diseases|March 31, 2012
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011D E Furst, E C Keystone, J Braun, et al.
Annals of the Rheumatic Diseases|February 23, 2011
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010D E Furst, E C Keystone, J Braun, et al.
Rheumatology (Oxford, England)|March 22, 2003
FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation studyA W Morgan, V H Keyte, S J Babbage, et al.
Arthritis Care & Research|May 31, 2014
Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry resultsM Juarez, T E Toms, P de Pablo, et al.
Pageof 59

Showing results (541-550 of 586) with videos related to

Sort By:
Pageof 59
Annals of the Rheumatic Diseases|December 7, 2010
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesS van Assen, N Agmon-Levin, O Elkayam, et al.
Arthritis and Rheumatism|August 16, 2000
Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine aloneS M Proudman, P G Conaghan, C Richardson, et al.
Annals of the Rheumatic Diseases|August 6, 2013
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)J L Nam, E Villeneuve, E M A Hensor, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapseC H Burgoyne, S L Field, A K Brown, et al.
Arthritis and Rheumatism|October 31, 2007
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinaprilA E Gliddon, C J Doré, C M Black, et al.
Nature|October 7, 2021
Fine-regolith production on asteroids controlled by rock porosityS Cambioni, M Delbo, G Poggiali, et al.
Annals of the Rheumatic Diseases|March 31, 2012
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011D E Furst, E C Keystone, J Braun, et al.
Annals of the Rheumatic Diseases|February 23, 2011
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010D E Furst, E C Keystone, J Braun, et al.
Rheumatology (Oxford, England)|March 22, 2003
FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation studyA W Morgan, V H Keyte, S J Babbage, et al.
Arthritis Care & Research|May 31, 2014
Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry resultsM Juarez, T E Toms, P de Pablo, et al.
Pageof 59